{"article_title": "Intuitive Surgical Gets CE Approval For New Device But Near-Term Uncertainties Remain", "article_keywords": ["uncertainties", "intuitive", "remain", "ce", "nearterm", "surgical", "device", "approval", "gets"], "article_url": "http://www.forbes.com/sites/greatspeculations/2014/06/27/intuitive-surgical-gets-ce-approval-for-new-device-but-near-term-uncertainties-remain/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Great Speculations", "og": {"site_name": "Forbes", "description": "While improved access in international markets is likely to help the company counter weak institutional/hospital spending in the U.S., concerns over cost-effectiveness, adverse events and rising liability lawsuits will continue to weigh on its performance in the near term. However, we expect the CE approval to help the company stabilize sales of its da Vinci surgical system in the long run.", "title": "Intuitive Surgical Gets CE Approval For New Device But Near-Term Uncertainties Remain", "url": "http://www.forbes.com/sites/greatspeculations/2014/06/27/intuitive-surgical-gets-ce-approval-for-new-device-but-near-term-uncertainties-remain/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-06-27T08:45:00-04:00", "type": "article"}, "twitter": {"image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "Intuitive Surgical Gets CE Approval For New Device But Near-Term Uncertainties Remain", "description": "While improved access in international markets is likely to help the company counter weak institutional/hospital spending in the U.S., concerns over cost-effectiveness, adverse events and rising liability lawsuits will continue to weigh on its performance in the near term. However, we expect the CE approval to help the company stabilize sales of its da Vinci surgical system in the long run.", "card": "summary_large_image", "site": "@forbes"}, "description": "While improved access in international markets is likely to help the company counter weak institutional/hospital spending in the U.S., concerns over cost-effectiveness, adverse events and rising liability lawsuits will continue to weigh on its performance in the near term. However, we expect the CE approval to help the company stabilize sales of its da Vinci surgical system in the long run.", "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Investing,Markets,Stocks,Intuitive Surgical", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/investing", "section": "Investing", "modified": "2014-06-27", "published": "2014-06-27", "id": "blogAndPostId/blog/post/25-129467"}, "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "news_keywords": "Investing,Markets,Stocks,Intuitive Surgical"}, "_id": "\"57477af46914bd0286fddcb0\"", "article_summary": ""}